Agenda-setting intelligence, analysis and advice for the global fashion community.
The social media platform will effectively ban most weight loss-related content from appearing on its app starting next month, according to a sweeping new set of community guidelines published on its website last week. The app has become ground zero for weight-loss drug content, as patients looking for more information about popular medications such as Novo Nordisk A/S’s Wegovy and Eli Lilly & Co.’s Zepbound turn to social media for answers.
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.
